mRNA Therapeutics Market Size, Share, Demand & Trends Forecast 2034
- Pallavi Garudkar
- Mar 10
- 3 min read
According to Fortune Business Insights the global mRNA therapeutics market size was valued at USD 6.01 billion in 2025. The market is projected to be worth USD 6.85 billion in 2026 and reach USD 26.06 billion by 2034, exhibiting a CAGR of 18.18% during the forecast period. The mRNA therapeutics market includes medical treatments based on messenger RNA (mRNA) technology, which instructs human cells to produce specific proteins that can prevent or treat diseases. This technology has gained significant attention due to its successful application in COVID-19 vaccines and advanced drug development.
Key Market Insights
Rising investments in mRNA drug discovery and development
Increasing clinical trials for mRNA-based therapies
Expansion of personalized medicine and gene-based therapies
Growing adoption of biotechnology platforms in pharmaceutical research
Get a Free Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/mrna-therapeutics-market-113411
Market Segmentation Analysis
By type, prophylactic mRNA therapies dominate, mainly due to vaccine applications.
By application, infectious diseases and oncology are major segments driving market growth.
By end-user, biotechnology and pharmaceutical companies hold the largest share, as they lead research and commercialization of mRNA therapeutics.
Regional Insights
North America: North America dominates the market due to strong biotechnology research infrastructure, advanced healthcare systems, and the presence of major pharmaceutical companies.
Europe: Europe represents a significant market driven by government support for biotechnology innovation and research funding.
Asia Pacific: Asia Pacific is expected to experience rapid growth due to expanding biotechnology industries and increasing investments in pharmaceutical research.
Rest of the World: Regions such as Latin America and the Middle East & Africa are gradually adopting advanced therapeutic technologies.
Key Takeaways
The mRNA therapeutics market is expected to reach USD 26.06 billion by 2034.
The success of mRNA vaccines has accelerated the development of new therapeutic applications.
Prophylactic mRNA therapies currently dominate the market.
North America leads the market, while Asia Pacific is expected to grow rapidly.
Key Players in the mRNA Therapeutics Market
Moderna Inc. (U.S.)
BioNTech (Germany)
Pfizer Inc. (U.S.)
CureVac SE (Germany)
GSK plc. (U.K.)
Sanofi (France)
Omega Therapeutics (U.S.)
Strand Therapeutics (U.S.)
Immunomic Therapeutics (U.S.)
Market Insights
What are the key insights of the mRNA Therapeutics Market?
mRNA technology allows cells to produce therapeutic proteins, enabling treatments for infectious diseases, cancer, and genetic disorders.
The success of mRNA-based COVID-19 vaccines significantly accelerated research and commercial interest in mRNA therapeutics.
Pharmaceutical companies are expanding pipelines for mRNA-based vaccines, cancer immunotherapies, and rare disease treatments.
Growing investments in biotechnology research are driving rapid innovation in mRNA drug development.
Key Industry Development:
January 2025: The U.S. Department of Health and Human Services (HHS) provided funding of USD 590 million to Moderna Inc. to boost the development of mRNA-based pandemic influenza vaccines. This funding is also aimed at improving mRNA platform capabilities in the U.S.
August 2024: The U.S. FDA granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula).
Get Your Customization Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/mrna-therapeutics-market-113411?utm_medium=seg
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights Pvt. Ltd.
9th Floor, Icon Tower,
Baner - Mahalunge Road, Baner,
Pune-411045, Maharashtra, India.
Phone:
US: +18339092966
UK: +448085020280
APAC: +91 744 740 1245Email: sales@fortunebusinessinsights.com
Comments